Hematology & Oncology Doctors in Cary, NC Accepting Medicare

7 Hematology & Oncology doctors found. Showing 1 - 7

Sheila A. Shine, N.P. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 300 Ashville Ave, Ste 310, Cary, NC 27518 Phone: 919-233-8585    Fax: 919-233-8566

Suzanne L. Kirby, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 300 Ashville Ave, Suite 310, Cary, NC 27518 Phone: 919-233-8585    Fax: 919-233-8566

Charles Fredrick Eisenbeis, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 150 Parkway Office Ct Ste 200, Cary, NC 27518 Phone: 984-974-2150

Paramjeet Singh, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 216 Ashville Ave, Cary, NC 27511 Phone: 919-854-6900

Dr. Amit R Mehta, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 550 New Waverly Place Suite 120, Cary, NC 27518 Phone: 919-351-2260    Fax: 919-230-2311

Maha A. Elkordy, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 216 Ashville Ave, Cary, NC 27511 Phone: 919-854-6900

William C Waterfield, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1020 Southhill Dr, Ste 200, Cary, NC 27513 Phone: 919-659-1678

News Archive

Los Angeles Times examines how Miss. Delta region hopes to learn from Iran's rural health care

The Los Angeles Times reports on how health workers in the Mississippi Delta region of the U.S. are hoping to mimic Iran's success in reducing infant mortality by recreating the country's low-cost rural healthcare delivery system in their own backyard.

J-LANCELOT trial finds E5555 may reduce MACE without increasing serious bleeding events

Aspirin and thienopyridine antiplatelet therapy (such as clopidogrel) are standard care in the treatment of acute coronary syndrome (ACS) and even in stable coronary artery disease (CAD) after coronary intervention with stent. However, effective antiplatelet agents are needed which do not increase the risk of bleeding.

Researchers find no overall recovery benefit to patients treated with clot-removal devices

When someone has a stroke, time equals brain. The longer a stroke is left untreated, the more brain tissue is lost. Since the only proven treatment - a clot-busting drug - works in less than half of patients, stroke physicians had high hopes for a mechanical device that could travel through the blocked blood vessel to retrieve or break up the clot, restoring blood flow to the brain.

Human Circuit receives 2012 ProAV Spotlight Award in Medical/Healthcare category

Human Circuit announced today that it was awarded the 2012 ProAV Spotlight Award in the Medical/Healthcare category for their work on an innovative and revolutionary integration project for Baystate Medical, Hospital of the Future in Springfield, MA.

DPS Health introduces Virtual Lifestyle Management, forms partnership with Stanford Patient Education Research Center

DPS Health, a leader in digital behavior change interventions for emergent-risk populations, announced today the launch of its health self-management solution. Designed for health plans, providers systems and employers that are setting population health strategies for the emergent-risk population – adults with one or more pre-chronic or early-stage chronic conditions – the solution includes multi-channel consumer engagement to educate and enroll populations, Virtual Lifestyle ManagementTM to help individuals embrace healthy lifestyles, and a suite of condition-based, self-management programs to help the same individuals manage the impact of one or more conditions.

Read more Medical News

› Verified 7 days ago